Skip to content

About us

We develop new platform technologies to more effectively diagnose and treat cancer. We primarily develop molecular imaging and phototherapy agents as well as nature-inspired theranostic nanomedicines, with a focus on creating clinically translatable technologies.





🎉Congratulations to Jenny on having her paper published at @Biomaterials_! Read about how PDT mediates the immune response to cancers with and without immune checkpoint therapy here:

Designed using Unos. Powered by WordPress.